Annual Conference 2014

131 - Hypogonadism: Diagnosis, Management, and Controversial Issues

Nov 1, 2014 11:00am ‐ Nov 1, 2014 12:00pm

Standard: $20.00
Members: $0.00

Description

The evaluation and management of hypogonadism is discussed during this presentation. Topical, injectable, and implantable testosterone therapy are reviewed. Controversial issues associated with testosterone replacement therapy are also discussed.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
• List four components of the patient history when the patient presents with low testosterone.
• Name three rooutes of adminstration of testosterone replacement therapy.
• Describe the controverial issues surrounding testosterone replacement therapy.

Speaker(s):

You must be logged in and own this session in order to post comments.